Cervical Cancer Clinical Trials in Hangzhou, Zhejiang
15 recruitingHangzhou, Zhejiang, China
Showing 1–15 of 15 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled239 locationsNCT06459180
Recruiting
Phase 1Phase 2
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Cervical CancerUrothelial CarcinomaMelanoma+8 more
Bristol-Myers Squibb949 enrolled50 locationsNCT04895709
Recruiting
Phase 1Phase 2
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
Cervical Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd120 enrolled1 locationNCT07080216
Recruiting
Phase 2
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Cervical CancerImmunochemotherapy
Women's Hospital School Of Medicine Zhejiang University59 enrolled1 locationNCT07167160
Recruiting
A Cohort Study of Uterine Malignancies
Cervical CancerEndometrial Cancer
Women's Hospital School Of Medicine Zhejiang University6,200 enrolled1 locationNCT05635123
Recruiting
Phase 3
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
Cervical Cancer
Lee's Pharmaceutical Limited440 enrolled5 locationsNCT06459687
Recruiting
Not Applicable
Modified Tumor-free Techniques Operation to Cervical Cancer
Cervical Cancer Stage IB2
Peking Union Medical College Hospital524 enrolled13 locationsNCT06836869
Recruiting
Phase 2
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
Cervical CancerNeoadjuvant ChemoimmunotherapyLocally Advanced Cervical Cancer+1 more
Tongji Hospital40 enrolled12 locationsNCT06288360
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.200 enrolled24 locationsNCT06799637
Recruiting
Phase 2Phase 3
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Cervical CancerConcurrent ChemoradiotherapyNeoadjuvant Chemoimmunotherapy+1 more
Tongji Hospital440 enrolled12 locationsNCT06288373
Recruiting
Phase 2
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Ovarian CancerCervical Cancer
Shandong University83 enrolled6 locationsNCT06251947
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Phase 2
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
Cervical Cancer
RemeGen Co., Ltd.116 enrolled12 locationsNCT06155396
Recruiting
Radiomics-based Malnutrition for Cervical Cancer.
Cervical CancerMalnutrition
Zhejiang Provincial People's Hospital150 enrolled1 locationNCT05709769
Recruiting
Phase 3
Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer
Cervical Cancer
Zhejiang Cancer Hospital455 enrolled7 locationsNCT04974346